News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Micrologix Biotech Inc. (MGIXF) Third Quarter Results Conference Call & Web Cast Notification


10/19/2005 5:10:21 PM

VANCOUVER, March 8 /PRNewswire-FirstCall/ -- Micrologix Biotech Inc. (TSX: MBI; OTC: MGIXF) will host a conference call and web cast on Thursday, March 11, 2004 at 9:00 a.m. ET (6:00 a.m. PT) to discuss financial results for the third quarter ended January 31, 2004 and provide an update on company activities. To participate in the conference call, please dial 416-405-9310 or

1-877-211-7911. The call will be available for replay until March 25, 2004 by calling 1-800-408-3053 or 416-695-5800 and entering the pass code 3009242. The live and archived web cast can be accessed through the company's website at http://www.mbiotech.com/.

About Micrologix

Micrologix Biotech Inc. is engaged in the research, development, and commercialization of drugs that advance therapy, improve health, and enrich lives. The Company's focus is toward anti-infective drug development with four product candidates in human clinical development, multiple product opportunities in preclinical development, and several early-stage technologies in various stages of research and evaluation.

Micrologix Biotech Inc.

CONTACT: Investor & Media Relations Contacts: JonathanBurke, Micrologix Biotech Inc., Telephone: (604) 221-9666 Extension 241,Email: jburke@mbiotech.com; Gino de Jesus or Dian Griesel, Ph.D, TheInvestor Relations Group, Telephone: (212) 825-3210, Email:theproteam@aol.com;To request a free copy of this organization's annual report, please go tohttp://www.newswire.ca/ and click on reports@cnw.


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES